Home    Guidelines & JOGC    Guidelines    Guideline Resource Kit

Guideline Resource Kit

Each month, the SOGC publishes 1-2 Clinical Practice Guidelines, Committee Opinions or Technical Updates.  We are excited to announce a "Guideline Resource Kit" that will follow the release of each future publication with a variety of complementary tools and learning opportunities. Exclusive to SOGC members, these resources aim to increase uptake and dissemination of new information in the scope of women’s health. This suite of resources will now be available through the SOGC online portal TopClass, where members can complete accredited “Test Your Knowledge” activities to earn CME credits and access member-only materials that supplement the content from each publication. 

It is our goal to provide novel continuous learning activities that promote acquisition of new knowledge, skills and attitudes to maintain professional competency.

We hope you enjoy this membership benefit and find value in the added resources.

This activity is for SOGC members only. 

Skip to search results
Alcohol Consumption During Pregnancy
The 2020 Clinical Practice Guideline for Screening and Counselling for Alcohol Consumption During Pregnancy aims to establish national standards of care for screening and counselling pregnant women and women of child-bearing age about alcohol consumption. In addition, the guideline outlines evidence-based approaches to care for women who may have alcohol use disorder. The guideline reviews brief intervention practices, alcohol screening tools, motivational interviewing,... Details
When: February 6, 2020 – December 31, 2025
Conservative Care of Urinary Incontinence in Women
Urinary incontinence is a common and significant issue that many women may experience at various stages throughout their lives. Proper determination of etiology is required to offer the most effective management options for urinary incontinence. The 2020 SOGC Clinical Practice Guideline on the Conservative Care of Urinary Incontinence Among Women, summarizes recommendations for assessment and management options for stress, urge and mixed related urinary incontinence. The guideline... Details
When: February 6, 2020 – December 31, 2025
Diagnosis and Management of Placenta Previa
The incidence of placenta previa is increasing, and an appropriate diagnosis is important to ensure women receive the care they need throughout gestation. Placenta previa is a condition where the placenta overlies the cervix, while low-lying placenta occurs when the placenta is close to the cervical os. The 2020 SOGC Clinical Practice Guideline for the Diagnosis and Management of Placenta Previa reviews the classification, diagnosis and antenatal management of placenta previa and... Details
When: February 6, 2020 – December 31, 2025
Female Genital Cutting
Female genital cutting is internationally recognized as a harmful practice and a direct violation of girls’ and women’s rights. The World Health Organization defines FGC as “all procedures involving partial or total removal of the external female genitalia or injury to the female genital organs for non-medical reasons.” Practising or assisting with FGC is illegal in Canada and will result in criminal charges and conviction. Globally, the prevalence rate of FGC is 10%, and as a... Details
When: February 6, 2020 – December 31, 2025
Fetal Health Surveillance
The 2020 SOGC Clinical Practice Guideline No. 396 -Fetal Health Surveillance presents evidence and recommendations regarding the use, classification, interpretation, response and documentation of fetal surveillance in the intrapartum period. This information is useful for all members of the intrapartum team to assure appropriate and efficient care is given to women and their fetus. This guideline reviews methods of uterine activity assessment and fetal heart rate surveillance. After... Details
When: February 6, 2020 – December 31, 2025
IFD Testing in Women with Chronic Viral Infections
Chronic maternal viral infections, including Hepatitis B, C and human immunodeficiency virus (HIV), require viral suppression in order to decrease the risk of vertical transmission. This clinical practice guideline reviews non-invasive screening tests and intrauterine fetal diagnostic testing options for Hepatitis B, C and HIV. Prior to any test procedure, healthcare providers should review the benefits and risks associated with the test in order to ensure the patient can make an... Details
When: December 14, 2020 – December 31, 2025
Investigation & Management: Adnexal & Benign Ovarian Masses
Diagnosis of an ovarian lesion is often associated with fear for women. The 2020 SOGC Clinical Practice Guideline for the Management of the Benign Ovarian Lesion outlines the management of ovarian lesions that are characterized as benign on ultrasound. The guideline reviews management of patients who are asymptomatic or symptomatic with ovarian lesions, as well as technical considerations for surgery.  Ovarian cancer affects 2800 women annually in Canada. Adnexal masses, although... Details
When: February 6, 2020 – December 31, 2025
Management of Gestational Trophoblastic Diseases
Gestational Trophoblastic Diseases impact approximately 1 in 1000 pregnancies. This guideline reviews the clinical evaluation and management of gestational trophoblastic diseases in order to assist healthcare providers with appropriate and efficient diagnosis, standardized treatment and follow up. Following evidence-based best practice guidelines, these recommendations can help deliver early specialized care to patients with malignant or metastatic disease. After reviewing the... Details
When: February 1, 2021 – December 31, 2025
Management of Tick Bites and Lyme Disease During Pregnancy
Lyme disease is emerging in Canada and pregnant and postpartum women may be at risk of contracting this condition that is transmitted by a tick bite from an infected blacklegged tick. Lyme disease is treatable; however, late stage infection that is left untreated can result in neurological, joint and cardiac involvement. This committee opinion reviews diagnosis of early localized and late stage infection, treatment options and preventative strategies specifically for pregnant women.... Details
When: February 6, 2020 – December 31, 2025
Pregnancy Management for Fetal Neural Tube Defects
Neural tube defects result from the failed closure of the human neural tube, which normally occurs during the third to fourth week of embryonic development. In 2015, the rate of non-chromosomal neural tube defects ranged from 3.6-4.6 per 10,000 Canadian births. This guideline provides evidence-based recommendations for the prevention of fetal neural tube defects. Furthermore, the guideline outlines screening and diagnosis procedures, along with recommendations to counsel families on... Details
When: January 28, 2021 – December 31, 2025
Prenatal Testing After IVF for Aneuploidy
In vitro fertilization to conceive is increasing, and it is important that established criteria and effective methodologies are known and available to select the most suitable embryo(s) to transfer. This committee opinion reviews preimplantation genetic testing for aneuploidy (PGT-A), including the approach to screening and diagnosis for chromosomal abnormalities in pregnancies conceived through in virto fertilization. After reviewing the committee opinion, SOGC members may complete... Details
When: February 6, 2020 – December 31, 2025
Sonographic Cervical Length in Singleton Pregnancies
Preterm birth is the leading cause of perinatal morbidity. Measuring cervical length may help identify patients who are at risk of preterm delivery.  Ultrasonographic techniques are reviewed in the SOGC 2020 Clinical Practice Guideline, Ultrasonographic Cervical Length in Singleton Pregnancies: Natural history, technique and clinical applications. After reviewing the guideline, SOGC members may complete the Guideline Resource Kit which includes an online quiz that will contribute... Details
When: February 6, 2020 – December 31, 2025
Stillbirth Investigation
The Society of Obstetricians and Gynaecologists of Canada Clinical Practice Guideline No. 394 – Stillbirth Investigation, provides recommendations for investigating the cause of fetal death when etiology is unknown. The guideline summarizes risk factors, and describes in detail maternal and fetal investigations that may be performed. The Guideline Resource Kit provides a checklist for clinicians to use in their practice at the time of delivery to inform their decisions on what... Details
When: February 6, 2020 – December 31, 2025
Thyroid Disease and Infertility
In the past three years, large randomized controlled trials have been published addressing the screening and management of thyroid disease in the area of infertility and assisted reproduction. The SOGC 2020 Committee Opinion: Thyroid Disease and Infertility, reviews this emerging evidence, and offers recommendations for testing of thyroid stimulating hormone (TSH) and thyroid antibodies for women seeking care for infertility, and who have TSH elevations. In addition, this Committee... Details
When: February 6, 2020 – December 31, 2025
Use of Progesterone for Prevention of SPB
Preterm birth (delivery before 37 weeks gestation) affects 15 million pregnancies worldwide and significantly increases the risk for neonatal complications. Spontaneous preterm birth contributes largely to the prevalence of preterm birth. The 2020 SOGC Clinical practice guideline, "Use of Progesterone for Prevention of Spontaneous Preterm Birth", shares recent evidence on vaginal progesterone therapy to prevent the risk of spontaneous preterm birth. The guideline presents risk... Details
When: February 6, 2020 – December 31, 2025